{"id":"ceftriaxon","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Elevations of alanine aminotransferase (ALT)","drugRate":"3.3%","severity":"common","organSystem":""},{"effect":"Elevations of aspartate aminotransferase (AST)","drugRate":"3.1%","severity":"common","organSystem":""},{"effect":"Diarrhea/loose stools","drugRate":"2.7%","severity":"common","organSystem":""},{"effect":"Leukopenia","drugRate":"2.1%","severity":"common","organSystem":""},{"effect":"Rash","drugRate":"1.7%","severity":"common","organSystem":""},{"effect":"Elevations of BUN","drugRate":"1.2%","severity":"common","organSystem":""},{"effect":"Pain, induration and tenderness","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Granulocytopenia","drugRate":"0.9%","severity":"common","organSystem":""},{"effect":"Injection site pain","drugRate":"0.6%","severity":"common","organSystem":""},{"effect":"Blood creatinine increased","drugRate":"0.6%","severity":"common","organSystem":""},{"effect":"Coagulopathy","drugRate":"0.4%","severity":"common","organSystem":""},{"effect":"Genital fungal infection","drugRate":"0.1%","severity":"common","organSystem":""}],"contraindications":["Acute nephropathy","Disease of liver","Disorder of gallbladder","Hemolytic anemia","Neonatal hyperbilirubinemia","Pseudomembranous enterocolitis"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Anaphylaxis","drugRate":"0.1%","severity":"serious"},{"effect":"Stevens-Johnson syndrome","drugRate":"0.1%","severity":"serious"},{"effect":"Toxic epidermal necrolysis (Lyell's syndrome)","drugRate":"0.1%","severity":"serious"},{"effect":"Agranulocytosis","drugRate":"0.1%","severity":"serious"},{"effect":"Seizures","drugRate":"0.1%","severity":"serious"},{"effect":"Acute renal failure","drugRate":"0.1%","severity":"serious"},{"effect":"Bronchospasm","drugRate":"0.1%","severity":"serious"},{"effect":"Allergic pneumonitis","drugRate":"0.1%","severity":"serious"},{"effect":"Kernicterus","drugRate":"0.1%","severity":"serious"},{"effect":"Crystalline material precipitation (neonates)","drugRate":"0.1%","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL6067656","moleculeType":"Small molecule","molecularWeight":"1323.22"},"aliases":["Ceftriaxone (ATC code J01DD04)","Ceftriaxone"],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Ceftriaxon","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:02:24.417357+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:02:30.163384+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Ceftriaxon","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:02:31.222203+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Bacterial penicillin-binding protein inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:02:32.274574+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6067656/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:02:31.940864+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"9c801096-ca61-4b29-a1e1-5f7e7813b191","title":"CEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION [REMEDYREPACK INC.]"},"ecosystem":[],"mechanism":{"target":"Alpha-synuclein, D-amino-acid oxidase, Penicillin-binding protein 1A"},"_scrapedAt":"2026-03-28T00:29:49.855Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:02:33.642714+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Acute gonococcal cervicitis","diseaseId":"acute-gonococcal-cervicitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute gonococcal endometritis","diseaseId":"acute-gonococcal-endometritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute gonococcal urethritis","diseaseId":"acute-gonococcal-urethritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Adult Gonococcal Conjunctivitis","diseaseId":"adult-gonococcal-conjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial arthritis","diseaseId":"bacterial-arthritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial infection due to Klebsiella pneumoniae","diseaseId":"bacterial-infection-due-to-klebsiella-pneumoniae","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial infection due to Serratia","diseaseId":"bacterial-infection-due-to-serratia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial meningitis","diseaseId":"bacterial-meningitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial pneumonia","diseaseId":"bacterial-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial septicemia","diseaseId":"bacterial-septicemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial urinary infection","diseaseId":"bacterial-urinary-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chancroid","diseaseId":"chancroid","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Disseminated Gonococcal Infection","diseaseId":"disseminated-gonococcal-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"E. Coli Joint Infection","diseaseId":"e.-coli-joint-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"E. Coli Osteomyelitis","diseaseId":"e.-coli-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"E. Coli Peritonitis","diseaseId":"e.-coli-peritonitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"E. Coli Septic Arthritis","diseaseId":"e.-coli-septic-arthritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Endometritis","diseaseId":"endometritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Enterobacter Osteomyelitis","diseaseId":"enterobacter-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Enterobacter Pneumonia","diseaseId":"enterobacter-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"EnterobacterJoint Infection","diseaseId":"enterobacterjoint-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Escherichia coli meningitis","diseaseId":"escherichia-coli-meningitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Escherichia coli urinary tract infection","diseaseId":"escherichia-coli-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Female genital tract infection","diseaseId":"female-genital-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gonococcal endocarditis","diseaseId":"gonococcal-endocarditis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gonococcal infection of joint","diseaseId":"gonococcal-infection-of-joint","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gonococcal meningitis","diseaseId":"gonococcal-meningitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gonorrhea","diseaseId":"gonorrhea","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gonorrhea of pharynx","diseaseId":"gonorrhea-of-pharynx","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gonorrhea of rectum","diseaseId":"gonorrhea-of-rectum","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gram-Negative Aerobic Bacillary Pneumonia","diseaseId":"gram-negative-aerobic-bacillary-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"H. Influenzae Meningitis","diseaseId":"h.-influenzae-meningitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Haemophilus Influenzae Type B Infections","diseaseId":"haemophilus-influenzae-type-b-infections","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Haemophilus Osteomyelitis","diseaseId":"haemophilus-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Haemophilus Parainfluenzae Pneumonia","diseaseId":"haemophilus-parainfluenzae-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Haemophilus Septic Arthritis","diseaseId":"haemophilus-septic-arthritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Haemophilus Septicemia","diseaseId":"haemophilus-septicemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Haemophilus influenzae pneumonia","diseaseId":"haemophilus-influenzae-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection due to Enterobacteriaceae","diseaseId":"infection-due-to-enterobacteriaceae","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection due to Escherichia coli","diseaseId":"infection-due-to-escherichia-coli","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection of bone","diseaseId":"infection-of-bone","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection of skin AND/OR subcutaneous tissue","diseaseId":"infection-of-skin-and/or-subcutaneous-tissue","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infectious disease of abdomen","diseaseId":"infectious-disease-of-abdomen","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infectious disorder of joint","diseaseId":"infectious-disorder-of-joint","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infective otitis media","diseaseId":"infective-otitis-media","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Inflammatory Disease of Female Pelvic Organs","diseaseId":"inflammatory-disease-of-female-pelvic-organs","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Klebsiella Joint Infection","diseaseId":"klebsiella-joint-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Klebsiella Pneumoniae Osteomyelitis","diseaseId":"klebsiella-pneumoniae-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Klebsiella Pneumoniae Peritonitis","diseaseId":"klebsiella-pneumoniae-peritonitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Klebsiella cystitis","diseaseId":"klebsiella-cystitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Lower respiratory tract infection","diseaseId":"lower-respiratory-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Meningitis due to Klebsiella mobilis","diseaseId":"meningitis-due-to-klebsiella-mobilis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Meningococcal meningitis","diseaseId":"meningococcal-meningitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pelvic Inflammatory Disease with Neisseria Gonorrhea","diseaseId":"pelvic-inflammatory-disease-with-neisseria-gonorrhea","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Peptostreptococcus Peritonitis","diseaseId":"peptostreptococcus-peritonitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Peptostreptococcus infection","diseaseId":"peptostreptococcus-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumococcal meningitis","diseaseId":"pneumococcal-meningitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumonia due to Escherichia coli","diseaseId":"pneumonia-due-to-escherichia-coli","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumonia due to Streptococcus","diseaseId":"pneumonia-due-to-streptococcus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Prevention of Meningococcal Meningitis","diseaseId":"prevention-of-meningococcal-meningitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Prevention of Perioperative Infection","diseaseId":"prevention-of-perioperative-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Proteus Joint Infection","diseaseId":"proteus-joint-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Proteus Mirabilis Osteomyelitis","diseaseId":"proteus-mirabilis-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Proteus pneumonia","diseaseId":"proteus-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Proteus urinary tract infection","diseaseId":"proteus-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Rhinoscleroma","diseaseId":"rhinoscleroma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Salmonella septicemia","diseaseId":"salmonella-septicemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Septicemia due to Escherichia coli","diseaseId":"septicemia-due-to-escherichia-coli","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Skin and Skin Structure Morganella Morganii Infection","diseaseId":"skin-and-skin-structure-morganella-morganii-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Skin and Skin Structure Proteus Infection","diseaseId":"skin-and-skin-structure-proteus-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Skin and Skin Structure Serratia Infection","diseaseId":"skin-and-skin-structure-serratia-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Staphylococcal meningitis","diseaseId":"staphylococcal-meningitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Staphylococcal pneumonia","diseaseId":"staphylococcal-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Staphylococcal septicemia","diseaseId":"staphylococcal-septicemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Streptococcal Joint Infection","diseaseId":"streptococcal-joint-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Streptococcal meningitis","diseaseId":"streptococcal-meningitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Streptococcal septicemia","diseaseId":"streptococcal-septicemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Streptococcus Osteomyelitis","diseaseId":"streptococcus-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Streptococcus pyogenes infection","diseaseId":"streptococcus-pyogenes-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07207876","phase":"","title":"Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy","status":"RECRUITING","sponsor":"International Maternal Pediatric Adolescent AIDS Clinical Trials Group","startDate":"2026-02-16","conditions":"Pregnancy","enrollment":110},{"nctId":"NCT07484633","phase":"PHASE4","title":"A Randomised Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients.","status":"NOT_YET_RECRUITING","sponsor":"Semmelweis University","startDate":"2026-04","conditions":"Infection, Sepsis, NICU","enrollment":110},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT06406114","phase":"PHASE2","title":"Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-05-05","conditions":"Drug Allergy, Cephalosporin Allergy, Drug Hypersensitivity","enrollment":300},{"nctId":"NCT06611111","phase":"EARLY_PHASE1","title":"Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease","status":"RECRUITING","sponsor":"State University of New York - Upstate Medical University","startDate":"2025-02-03","conditions":"Post-Treatment Lyme Disease","enrollment":44},{"nctId":"NCT06080698","phase":"NA","title":"Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-02-22","conditions":"Gram-negative Bacteremia","enrollment":1030},{"nctId":"NCT07450404","phase":"","title":"PK/PD Target Attainment of Ceftriaxone for the Prevention of Early Ventilator-associated Pneumonia in Neurologically Injured Patients","status":"NOT_YET_RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2026-03-01","conditions":"Early Ventilator Associated Pneumonia, Acute Brain Injuries","enrollment":60},{"nctId":"NCT06494072","phase":"PHASE4","title":"Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2024-08-22","conditions":"Community Acquired Pneumonia in Children","enrollment":236},{"nctId":"NCT05294588","phase":"PHASE2","title":"Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-04-18","conditions":"Gonorrhea Male","enrollment":65},{"nctId":"NCT05980871","phase":"PHASE4","title":"Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline","status":"TERMINATED","sponsor":"National Taiwan University Hospital","startDate":"2023-03-10","conditions":"Early Syphilis","enrollment":109},{"nctId":"NCT06819592","phase":"PHASE3","title":"PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury","status":"RECRUITING","sponsor":"The George Institute","startDate":"2025-10-30","conditions":"All-cause Mortality, Quality of Life, Disability, Intellectual","enrollment":3300},{"nctId":"NCT02701595","phase":"PHASE3","title":"Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2016-02-29","conditions":"Infective Endocarditis","enrollment":324},{"nctId":"NCT06537609","phase":"NA","title":"A Platform Trial for Gram Negative Bloodstream Infections","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2024-04-24","conditions":"Gram-negative Bacteremia","enrollment":2500},{"nctId":"NCT05750966","phase":"NA","title":"Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2023-07-19","conditions":"Cholangitis","enrollment":440},{"nctId":"NCT06437964","phase":"NA","title":"Prophylactic Antibiotics in Endoscopic Secondary Prevention of Gastroesophageal Variceal Bleeding","status":"ACTIVE_NOT_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-05-25","conditions":"Cirrhosis, Liver, Hypertension, Portal, Variceal Hemorrhage","enrollment":226},{"nctId":"NCT04986254","phase":"","title":"PNEUmonia DOSing in Critically Ill Patients (PNEUDOS)","status":"COMPLETED","sponsor":"The University of Queensland","startDate":"2019-10-17","conditions":"Pneumonia","enrollment":179},{"nctId":"NCT06785402","phase":"PHASE1, PHASE2","title":"Ceftriaxone for Post-Treatment Lyme Disease","status":"RECRUITING","sponsor":"Hackensack Meridian Health","startDate":"2026-02-15","conditions":"Post-Treatment Lyme Disease Syndrome","enrollment":20},{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":"Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth","enrollment":56},{"nctId":"NCT06629324","phase":"PHASE2","title":"Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy From Brain Hypoxia","status":"RECRUITING","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2024-10-15","conditions":"Autism Spectrum Disorder","enrollment":58},{"nctId":"NCT07030673","phase":"NA","title":"Early Discontinuation of Antibiotic Therapy in Elderly Patients Hospitalized for a Viral Infection","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2025-02-14","conditions":"Elderly, Antibiotics Overuse, Viral Infections","enrollment":256},{"nctId":"NCT05074147","phase":"PHASE3","title":"Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2)","status":"WITHDRAWN","sponsor":"Tourcoing Hospital","startDate":"2022-05-01","conditions":"Osteomyelitis - Foot","enrollment":""},{"nctId":"NCT07332325","phase":"PHASE3","title":"STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2026-04","conditions":"Sepsis, Tuberculosis","enrollment":344},{"nctId":"NCT05960006","phase":"","title":"A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2023-07-10","conditions":"Antibiotic Toxicity, Liver Cirrhosis, Renal Insufficiency","enrollment":20},{"nctId":"NCT05544565","phase":"PHASE4","title":"3-day IV Antibiotic Treatment Versus 3-day IV Followed by 7-day Oral Antibiotic Treatment for AP in Children","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-03-22","conditions":"Pyelonephritis Acute","enrollment":480},{"nctId":"NCT07318584","phase":"PHASE2","title":"Cefotetan Therapy for Escherichia Coli Infections","status":"NOT_YET_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2026-03","conditions":"E Coli Infection, ESBL Producing E.Coli","enrollment":84},{"nctId":"NCT05079620","phase":"PHASE4","title":"Early Antibiotics After Aspiration in ICU Patients","status":"TERMINATED","sponsor":"UConn Health","startDate":"2021-11-30","conditions":"Aspiration, Aspiration Pneumonia","enrollment":5},{"nctId":"NCT07308457","phase":"NA","title":"Enhanced Molecular Microbiological Surveillance Versus Ceftriaxone Prophylaxis in Hematopoietic Cell Transplant Patients","status":"RECRUITING","sponsor":"Pomeranian Medical University Szczecin","startDate":"2024-09-01","conditions":"Incidence of Infectious Diseases","enrollment":100},{"nctId":"NCT03895567","phase":"PHASE1","title":"Study to Compare Blood Levels of Ceftriaxone Given by Suppository or Injection.","status":"SUSPENDED","sponsor":"University of Oxford","startDate":"2026-12","conditions":"Healthy","enrollment":37},{"nctId":"NCT07236944","phase":"PHASE4","title":"Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care","status":"RECRUITING","sponsor":"Uppsala University","startDate":"2025-12","conditions":"Febrile Urinary Tract Infection","enrollment":560},{"nctId":"NCT06294600","phase":"PHASE3","title":"Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)","status":"RECRUITING","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2024-02-12","conditions":"Community-acquired Pneumonia","enrollment":330},{"nctId":"NCT03012360","phase":"PHASE4","title":"Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2018-02-08","conditions":"Mechanical Ventilation Complication, Critical Illness","enrollment":103},{"nctId":"NCT07245966","phase":"","title":"Pharmacokinetics and Pharmacodynamics of High Dose Ceftriaxone in Patients With Sepsis","status":"COMPLETED","sponsor":"Prince of Songkla University","startDate":"2024-06-01","conditions":"Sepsis","enrollment":20},{"nctId":"NCT02473263","phase":"PHASE3","title":"Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic Shock","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-05-09","conditions":"Severe Septic Syndrome (Severe Sepsis and Septic Shock) Diagnosed and Treated by Mobile Intensive Care Unit","enrollment":398},{"nctId":"NCT01543334","phase":"","title":"Antibiotic Concentrations Among Critically Ill Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2012-03","conditions":"Administration of Antibiotics in Intensive Care Units","enrollment":98},{"nctId":"NCT07229755","phase":"PHASE2, PHASE3","title":"Comparison Between Effect of Empirical Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy in Children With Pyuria","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-07-01","conditions":"Urinary Tract Infection (Diagnosis)","enrollment":140},{"nctId":"NCT03959527","phase":"PHASE3","title":"Zoliflodacin in Uncomplicated Gonorrhoea","status":"COMPLETED","sponsor":"Global Antibiotics Research and Development Partnership","startDate":"2019-11-06","conditions":"Gonorrhea","enrollment":1011},{"nctId":"NCT03915366","phase":"PHASE2, PHASE3","title":"Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia","status":"COMPLETED","sponsor":"Hospital Universitario 12 de Octubre","startDate":"2020-03-01","conditions":"Pneumonia, HIV/AIDS, Tuberculosis","enrollment":563},{"nctId":"NCT03413384","phase":"PHASE2","title":"To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia","status":"ACTIVE_NOT_RECRUITING","sponsor":"BrainX Corporation","startDate":"2019-02-15","conditions":"Parkinson's Disease Dementia","enrollment":100},{"nctId":"NCT07169097","phase":"","title":"Study of the Pharmacokinetics of Ceftriaxone","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2024-09-30","conditions":"Urinary Infections","enrollment":300},{"nctId":"NCT03068741","phase":"PHASE4","title":"Paramedic Initiated Treatment of Sepsis Targeting Out-of-hospital Patients (PITSTOP)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Damon Scales","startDate":"2020-03-23","conditions":"Severe Sepsis or Septic Shock","enrollment":2040},{"nctId":"NCT07148622","phase":"NA","title":"Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2024-10-01","conditions":"Preterm Premature Rupture of Membranes (PPROM), Prophylaxis, Perinatal Outcomes","enrollment":40},{"nctId":"NCT03825874","phase":"","title":"Research of the Consequences on the Digestive Tract Following the Proposed Treatments for a Urinary Infection in Children","status":"RECRUITING","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2019-01-19","conditions":"Urinary Tract Infections, Urinary Tract Infections in Children","enrollment":200},{"nctId":"NCT05121974","phase":"PHASE2","title":"Tebipenem Trial in Children With Shigellosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2022-08-18","conditions":"Shigellosis","enrollment":132},{"nctId":"NCT02996656","phase":"NA","title":"Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery","status":"RECRUITING","sponsor":"Université de Montréal","startDate":"2016-12","conditions":"Propionibacterium Infection","enrollment":88},{"nctId":"NCT06423898","phase":"PHASE4","title":"Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.","status":"RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2024-10-09","conditions":"Endocarditis, Infective","enrollment":284},{"nctId":"NCT07082465","phase":"","title":"Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand","status":"NOT_YET_RECRUITING","sponsor":"University of Oxford","startDate":"2025-08-01","conditions":"Drug Resistance, Bacterial, Bacteremia","enrollment":108000},{"nctId":"NCT05821478","phase":"PHASE3","title":"Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients","status":"RECRUITING","sponsor":"Institut Pasteur","startDate":"2025-05-22","conditions":"Hidradenitis Suppurativa","enrollment":92},{"nctId":"NCT07026253","phase":"","title":"Comparative Analysis of Delirium in Older Adults Treated With Ceftazidime, Cefepime, or Ceftriaxone","status":"RECRUITING","sponsor":"Alexandria University","startDate":"2024-10-01","conditions":"Delirium","enrollment":120},{"nctId":"NCT06950229","phase":"NA","title":"Povidone Iodine Versus Normal Saline in Preoperative Vaginal Cleansing Before Caesarean Section","status":"COMPLETED","sponsor":"Federal Teaching Hospital Abakaliki","startDate":"2020-10-06","conditions":"Povidone Iodine, Normal Saline, Pre-operative","enrollment":224},{"nctId":"NCT06946498","phase":"NA","title":"First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.","status":"RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2023-05-23","conditions":"Suspected Malignant Lung Neoplasm, Pleural Effusion, Pleural Effusion, Malignant","enrollment":100},{"nctId":"NCT04999592","phase":"PHASE2","title":"Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)","status":"TERMINATED","sponsor":"David J. Gagnon","startDate":"2021-08-20","conditions":"Out-Of-Hospital Cardiac Arrest, Pneumonia","enrollment":53},{"nctId":"NCT04563325","phase":"PHASE4","title":"Oral-only Antibiotics for Bone and Joint Infections in Children","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2020-09-15","conditions":"Osteomyelitis, Septic Arthritis, Bone Infection","enrollment":180},{"nctId":"NCT04975945","phase":"PHASE4","title":"Assessing Parenteral Antibiotics Versus Single-time Intra-operative Intra-dermal Antibiotic Administration for Prevention of SSI","status":"WITHDRAWN","sponsor":"The Grant Medical College & Sir J.J. Group of Hospitals","startDate":"2021-08","conditions":"Surgical Wound Infection, Surgical Site Infection","enrollment":""},{"nctId":"NCT05470517","phase":"PHASE2","title":"Antibiotic Instillation in Appendicitis","status":"COMPLETED","sponsor":"Johns Hopkins All Children's Hospital","startDate":"2023-01-05","conditions":"Complicated Appendicitis, Acute Appendicitis","enrollment":190},{"nctId":"NCT06113939","phase":"NA","title":"Prevention of Infection of the Respiratory Tract Through Application of Non-Invasive Methods of Secretion Suctioning","status":"NOT_YET_RECRUITING","sponsor":"Hospital San Carlos, Madrid","startDate":"2025-05-19","conditions":"Intubation Complication, Stroke, Ischemic, Stroke Hemorrhagic","enrollment":60},{"nctId":"NCT06828952","phase":"","title":"Risk Factors of Failure of Conservative Treatment in Acute Non Complicated Appendicitis","status":"NOT_YET_RECRUITING","sponsor":"Ahmed Mohammed Hussein Sayed","startDate":"2025-06-22","conditions":"Conservative Management","enrollment":100},{"nctId":"NCT05929599","phase":"NA","title":"Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Children's Hospital, Vietnam","startDate":"2023-07-05","conditions":"Acute Respiratory Tract Infections, Pneumonia, Respiratory Syncytial Virus (RSV)","enrollment":120},{"nctId":"NCT06166381","phase":"NA","title":"Parenteral Versus Combined Parenteral With Vancomycin-soaked Graft in ACL Reconstruction","status":"RECRUITING","sponsor":"University of Duhok","startDate":"2024-01-25","conditions":"Infection, Bacterial","enrollment":288},{"nctId":"NCT05849090","phase":"EARLY_PHASE1","title":"Vancomycin and Tobramycin Powder Use in Acute Open Fractures","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-03-27","conditions":"Infections","enrollment":10},{"nctId":"NCT05812820","phase":"NA","title":"Effects of Probiotic in Treatment of Persistent Diarrhea in Children","status":"COMPLETED","sponsor":"National Children's Hospital, Vietnam","startDate":"2022-07-01","conditions":"Diarrhea","enrollment":165},{"nctId":"NCT05899140","phase":"PHASE4","title":"Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial","status":"RECRUITING","sponsor":"Frieder Schaumburg","startDate":"2024-03-15","conditions":"Skin Infection, Staphylococcal Infections, Staphylococcus Aureus Infection","enrollment":100},{"nctId":"NCT03724903","phase":"NA","title":"Ductal Lavage Versus Corticosteroids Therapy for Idiopathic Granulomatous Mastitis","status":"COMPLETED","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2019-04-01","conditions":"Granulomatous Mastitis","enrollment":140},{"nctId":"NCT05893147","phase":"NA","title":"BALANCE+ Vanguard Phase","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2023-08-26","conditions":"Gram-negative Bacteremia","enrollment":174},{"nctId":"NCT06616168","phase":"PHASE1","title":"Urogenital Infections in Women of Reproductive Age and the Activity of 4-Thiazolidinone Derivatives Against Pathogens","status":"ACTIVE_NOT_RECRUITING","sponsor":"Danylo Halytsky Lviv National Medical University","startDate":"2023-09-01","conditions":"Bacterial Vaginosis","enrollment":200},{"nctId":"NCT06572761","phase":"PHASE3","title":"A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-09","conditions":"Previable Labour With Intact Membranes","enrollment":350},{"nctId":"NCT05027516","phase":"PHASE4","title":"Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2022-01-17","conditions":"Neisseria Gonorrhoeae","enrollment":42},{"nctId":"NCT06532409","phase":"NA","title":"Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone","status":"NOT_YET_RECRUITING","sponsor":"RESnTEC, Institute of Research","startDate":"2024-10-01","conditions":"Community-acquired Pneumonia","enrollment":114},{"nctId":"NCT06527989","phase":"PHASE2, PHASE3","title":"Prophylactic Antibiotic in Subtalar Fusion Surgery","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-09-01","conditions":"Surgical Site Infection","enrollment":102},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04041791","phase":"PHASE3","title":"A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-08-19","conditions":"Pneumonia","enrollment":4392},{"nctId":"NCT06454643","phase":"NA","title":"Gentamicin in Cardiac Surgery","status":"COMPLETED","sponsor":"Al-Rasheed University College","startDate":"2020-01-01","conditions":"Cardiac Infection","enrollment":50},{"nctId":"NCT04010539","phase":"PHASE3","title":"A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-10-21","conditions":"Gonorrhea","enrollment":628},{"nctId":"NCT05725226","phase":"NA","title":"Comparison Between 6Fr Vs 4Fr Double J Stent","status":"COMPLETED","sponsor":"Tribhuvan University, Nepal","startDate":"2023-04-07","conditions":"Renal Stone, Ureter Stone","enrollment":110},{"nctId":"NCT02424461","phase":"PHASE3","title":"Antibiotic Treatment for 7 Days Versus 14 Days in Patients With Acute Male Urinary Tract Infection","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-01-25","conditions":"Acute Male Urinary Tract Infection","enrollment":274},{"nctId":"NCT05002413","phase":"","title":"Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis","status":"COMPLETED","sponsor":"Resistell AG","startDate":"2021-06-18","conditions":"Bacteremia Sepsis","enrollment":300},{"nctId":"NCT06349122","phase":"PHASE4","title":"Screen-and-treat Strategy for Vaginal Flora Abnormalities in Pregnant Women at High Risk of Preterm Birth","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2024-08","conditions":"Bacterial Vaginosis, Vaginal Dysbiosis, Premature Delivery","enrollment":1292},{"nctId":"NCT03681431","phase":"PHASE2","title":"Evaluation of an Antibiotic Regimen Pharmacokinetic Applicable to Enterococcus Faecalis Infective Endocarditis","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2018-04-23","conditions":"Infectious Endocarditis","enrollment":12},{"nctId":"NCT05724628","phase":"PHASE1","title":"Non-operative vs. Operative Management of Acute Appendicitis in Vulnerable Patient Populations","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2023-10","conditions":"Acute Appendicitis","enrollment":""},{"nctId":"NCT05761405","phase":"EARLY_PHASE1","title":"Potentiated Aminoglycosides in Postoperative Urinary Tract Infection Prophylaxis","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2024-01-16","conditions":"Urinary Tract Infections, Urological System Complication of Procedure","enrollment":90},{"nctId":"NCT05925140","phase":"PHASE1","title":"LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients","status":"UNKNOWN","sponsor":"Lebanese University","startDate":"2020-03-28","conditions":"COVID-19, Hospitalized COVID-19 Patients","enrollment":1000},{"nctId":"NCT06220929","phase":"PHASE4","title":"Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury","status":"UNKNOWN","sponsor":"Sichuan Provincial People's Hospital","startDate":"2024-01-15","conditions":"Sepsis, Liver Dysfunction","enrollment":40},{"nctId":"NCT03289351","phase":"PHASE4","title":"Two Different Antibiotics Versus One Antibiotic for Pediatric Perforated Appendicitis","status":"COMPLETED","sponsor":"Phoenix Children's Hospital","startDate":"2017-05-22","conditions":"Perforated Appendicitis, Postoperative Infection","enrollment":162},{"nctId":"NCT04724044","phase":"PHASE3","title":"Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2021-01-25","conditions":"Community-acquired Pneumonia, Sepsis, Inflammatory Response","enrollment":278},{"nctId":"NCT05156437","phase":"PHASE4","title":"Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)","status":"ENROLLING_BY_INVITATION","sponsor":"Vinay Badhwar","startDate":"2022-03-16","conditions":"Endocarditis","enrollment":20},{"nctId":"NCT05199324","phase":"PHASE4","title":"Early Oral Step-down Antibiotic Therapy for Uncomplicated Gram-negative Bacteraemia","status":"UNKNOWN","sponsor":"Tan Tock Seng Hospital","startDate":"2022-04-01","conditions":"Gram-negative Bacteraemia","enrollment":720},{"nctId":"NCT04977882","phase":"EARLY_PHASE1","title":"Abdominal Drainage, Postoperative Antibiotico-prophylaxis and CME With D3 Lyphadenectomy Effect on Gastrointestinal Function in Laparoscopic Right Hemicolectomy With Intracorporeal Anastomosis for Right Colon Cancer","status":"COMPLETED","sponsor":"University of Rome Tor Vergata","startDate":"2020-10-01","conditions":"Colon Cancer","enrollment":36},{"nctId":"NCT03179384","phase":"PHASE4","title":"Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2017-06-26","conditions":"Pyelonephritis Acute","enrollment":9},{"nctId":"NCT05742139","phase":"","title":"Impact on the Quality of Life and Persistent Symptoms of Patients Away From Diagnosed and Treated Neuroborreliosis","status":"COMPLETED","sponsor":"Hopital Nord Franche-Comte","startDate":"2023-02-27","conditions":"Neuroborreliosis, Lyme, Quality of Life","enrollment":159},{"nctId":"NCT06090565","phase":"PHASE4","title":"Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea","status":"COMPLETED","sponsor":"Bulovka Hospital","startDate":"2021-04-01","conditions":"Gonorrhea","enrollment":161},{"nctId":"NCT05624229","phase":"PHASE4","title":"Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2023-10-01","conditions":"Upper Gastrointestinal Hemorrhage","enrollment":672},{"nctId":"NCT05149287","phase":"PHASE2","title":"PROPER Trial of Pain and Inflammation After Knee Arthroscopy","status":"TERMINATED","sponsor":"Austin V Stone","startDate":"2021-12-28","conditions":"Meniscus Tear, Meniscus Lesion, Cartilage Injury","enrollment":5},{"nctId":"NCT02389036","phase":"PHASE3","title":"Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients","status":"COMPLETED","sponsor":"The George Institute","startDate":"2017-05-01","conditions":"Critical Illness, Sepsis, Septic Shock","enrollment":20010},{"nctId":"NCT05971550","phase":"PHASE3","title":"Clearance of Asymptomatic Pharyngeal Carriage of Neisseria Gonorrhoeae With or Without Ceftriaxone Treatment: Randomized Non-inferiority Study","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-09","conditions":"Neisseria Gonorrhoeae Infection, Asymptomatic Pharyngeal Carriage","enrollment":254},{"nctId":"NCT05293132","phase":"PHASE2, PHASE3","title":"Effect of Montelukast Versus Co Enzyme in Sepsis","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-02-01","conditions":"Sepsis","enrollment":90},{"nctId":"NCT05943223","phase":"PHASE2","title":"Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)","status":"UNKNOWN","sponsor":"McMaster Children's Hospital","startDate":"2024-01","conditions":"Appendicitis Perforated","enrollment":16},{"nctId":"NCT05398081","phase":"PHASE2","title":"Cefuroxime vs Ceftriaxone for SSI Prevention in Neurosurgery","status":"COMPLETED","sponsor":"Dr. Promise Tamunoipiriala Jaja","startDate":"2021-12-01","conditions":"Surgical Site Infection, Antibiotics Prophylaxis","enrollment":96},{"nctId":"NCT03641690","phase":"","title":"Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2013-09-01","conditions":"H1N1 Influenza","enrollment":97},{"nctId":"NCT03439124","phase":"PHASE3","title":"Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia","status":"COMPLETED","sponsor":"Basilea Pharmaceutica","startDate":"2017-11-27","conditions":"Community-acquired Pneumonia (CAP), Hospital-acquired Pneumonia (HAP)","enrollment":138},{"nctId":"NCT00138801","phase":"PHASE3","title":"Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis","status":"COMPLETED","sponsor":"Sorlandet Hospital HF","startDate":"2004-03","conditions":"Lyme Neuroborreliosis","enrollment":120},{"nctId":"NCT02800785","phase":"NA","title":"The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial","status":"COMPLETED","sponsor":"University of Washington","startDate":"2016-05","conditions":"Appendicitis","enrollment":1552}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL6067656"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":170,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Ceftriaxon","genericName":"Ceftriaxon","companyName":"Centre Hospitalier Universitaire Vaudois","companyId":"centre-hospitalier-universitaire-vaudois","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:02:33.642714+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}